| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 2.1 | 0.7 | 3.0 |
| Other income | 0.3 | 0.4 | 0.5 |
| Total income | 2.4 | 1.1 | 3.5 |
| Profit before exceptional items & tax | -0.1 | 0.3 | -0.9 |
| Profit before tax | -0.1 | 0.3 | -0.9 |
| Net profit | -0.1 | 0.3 | -0.9 |
| Operating margin | -4.2% | 27.3% | -25.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -30.00% |
|---|
BSE results filing, NSE: SHREEGANES. Figures extracted from the filing.
Shree Ganesh Bio-Tech (India) Ltd: key numbers
- Share price
- ₹0.47
- Market cap
- ₹18.74 Cr
- Revenue (annual)
- ₹4.97 Cr
- Net profit (annual)
- ₹0.38 Cr
- P/E (TTM)
- -48.5×Sector 47.4×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 1.42%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shree Ganesh Bio-Tech (India) Ltd
All →Shree Ganesh Bio-Tech (India) Annual Report
Shree Ganesh Bio-Tech (India) Limited has released its Annual Report for the financial year 2025-26. The 16th Annual General Meeting is scheduled for September 28, 2026.
Shree Ganesh Bio-Tech (India) Annual General Meeting
Shree Ganesh Bio-Tech (India) Limited has issued a notice for its 16th Annual General Meeting. The meeting is scheduled for September 28, 2026, at the registered office.
Shree Ganesh Bio-Tech (India) Other Announcement
Shree Ganesh Biotech (India) Limited has updated its official website address to www.shreeganeshbiotech.bar. Exchanges are requested to update their records accordingly.
Shree Ganesh Bio-Tech (India) Other Announcement
Shree Ganesh Biotech (India) Limited has declared that it has no unutilised funds from any prior public issues, rights issues, or preferential placements as of June 2026.
Shree Ganesh Bio-Tech (India) Q1 FY27 Results: Net Loss of ₹0.6 Cr
Shree Ganesh Bio-Tech (India) Ltd reported revenue from operations of ₹1.4 Cr (+0.0% YoY) and a net loss of ₹0.6 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.6 Cr
Shree Ganesh Bio-Tech (India) Board Meeting Date
Shree Ganesh Bio-Tech has scheduled a board meeting for August 4, 2026, to consider and approve its un-audited financial results for the quarter ended June 30, 2026.